Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB… by engineering viruses at the genome level.
In this way, we can program tailor‑made viruses and viral platform vectors for therapeutic use and produce them biotechnologically, e.g. to combat cancer.
apl. Prof. Dr. Susanne Bailer
Cell destruction (plaque formation) after infection of cells with green fluorescent HSV1 viruses.